HEADER OXIDOREDUCTASE 02-JUN-11 3SA1 TITLE BACUILLS ANTHRACIS DIHYDROFOLATE REDUCTASE BOUND PROPARGYL-LINKED TMP TITLE 2 ANALOG, UCP1021 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDROFOLATE REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 1.5.1.3; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS ANTHRACIS; SOURCE 3 ORGANISM_COMMON: ANTHRAX,ANTHRAX BACTERIUM; SOURCE 4 ORGANISM_TAXID: 1392; SOURCE 5 GENE: BAS2083, BA_2237, DFRA, GBAA2237, GBAA_2237; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 1007065; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: M15; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PQE2 KEYWDS OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR A.C.ANDERSON,J.M.BEIERLEIN REVDAT 2 13-SEP-23 3SA1 1 REMARK SEQADV REVDAT 1 13-JUN-12 3SA1 0 JRNL AUTH A.C.ANDERSON,J.M.BEIERLEIN,K.VISWANATHAN,D.L.WRIGHT JRNL TITL SAR STUDIES OF HETEROCYCLIC PROPARGYL-LINKED TMP ANALOGS TO JRNL TITL 2 BACILLUS DIHYDROFOLATE REDUCTASE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.63 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 13963 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.230 REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 699 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.57 REMARK 3 REFLECTION IN BIN (WORKING SET) : 966 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.55 REMARK 3 BIN R VALUE (WORKING SET) : 0.2710 REMARK 3 BIN FREE R VALUE SET COUNT : 53 REMARK 3 BIN FREE R VALUE : 0.3470 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2750 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 150 REMARK 3 SOLVENT ATOMS : 35 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.79 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.309 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.214 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.460 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.918 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.887 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3011 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4093 ; 1.337 ; 2.002 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 333 ; 6.113 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 155 ;37.242 ;24.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 497 ;15.306 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;11.501 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 409 ; 0.087 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2320 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1646 ; 0.565 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2678 ; 1.076 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1365 ; 1.281 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1412 ; 2.156 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 13 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 1 A 10 3 REMARK 3 1 B 1 B 10 3 REMARK 3 2 A 25 A 29 3 REMARK 3 2 B 25 B 29 3 REMARK 3 3 A 31 A 32 3 REMARK 3 3 B 31 B 32 3 REMARK 3 4 A 35 A 36 3 REMARK 3 4 B 35 B 36 3 REMARK 3 5 A 38 A 71 3 REMARK 3 5 B 38 B 71 3 REMARK 3 6 A 73 A 81 3 REMARK 3 6 B 73 B 81 3 REMARK 3 7 A 83 A 87 3 REMARK 3 7 B 83 B 87 3 REMARK 3 8 A 89 A 90 3 REMARK 3 8 B 89 B 90 3 REMARK 3 9 A 92 A 128 3 REMARK 3 9 B 92 B 128 3 REMARK 3 10 A 137 A 146 3 REMARK 3 10 B 137 B 146 3 REMARK 3 11 A 149 A 160 3 REMARK 3 11 B 149 B 160 3 REMARK 3 12 A 20 A 23 3 REMARK 3 12 B 20 B 23 3 REMARK 3 13 A 12 A 18 3 REMARK 3 13 B 12 B 18 3 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 1 A (A): 555 ; 0.030 ; 0.050 REMARK 3 LOOSE POSITIONAL 1 A (A): 584 ; 0.040 ; 5.000 REMARK 3 TIGHT THERMAL 1 A (A**2): 555 ; 0.080 ; 0.500 REMARK 3 LOOSE THERMAL 1 A (A**2): 584 ; 0.080 ;10.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 3SA1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-JUN-11. REMARK 100 THE DEPOSITION ID IS D_1000065949. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-DEC-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK 9.9.8.8L, SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13990 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 42.630 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 5.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.13800 REMARK 200 R SYM (I) : 0.13800 REMARK 200 FOR THE DATA SET : 5.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.57 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.38300 REMARK 200 R SYM FOR SHELL (I) : 0.38300 REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3E0B REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.61 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: INITIAL CRYSTAL HITS WERE GROWN IN REMARK 280 27.5% (W/V) PEG 10,000, 0.1 M MES, PH 6.50, AT AN EQUAL RATIO OF REMARK 280 PROTEIN TO CRYSTALLIZATION SOLUTION. MICROSEEDING WAS USED TO REMARK 280 OBTAIN ISOLATED CRYSTALS IN 10% (W/V) PEG 10,000 AND 0.1 MES, PH REMARK 280 6.50 AT A PROTEIN CONCENTRATION OF 5 MG/ML, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 42 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y,X,Z+1/2 REMARK 290 4555 Y,-X,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 33.53500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 33.53500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A -2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP A 207 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 6DR A 163 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP B 207 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 6DR B 163 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3SA2 RELATED DB: PDB REMARK 900 RELATED ID: 3SAI RELATED DB: PDB REMARK 900 RELATED ID: 3E0B RELATED DB: PDB REMARK 900 RELATED ID: 3S9U RELATED DB: PDB REMARK 900 RELATED ID: 3JVX RELATED DB: PDB REMARK 900 RELATED ID: 3JWM RELATED DB: PDB REMARK 900 RELATED ID: 3JWC RELATED DB: PDB REMARK 900 RELATED ID: 3JWF RELATED DB: PDB DBREF 3SA1 A 1 162 UNP Q81R22 Q81R22_BACAN 1 162 DBREF 3SA1 B 1 162 UNP Q81R22 Q81R22_BACAN 1 162 SEQADV 3SA1 HIS A -2 UNP Q81R22 EXPRESSION TAG SEQADV 3SA1 HIS A -1 UNP Q81R22 EXPRESSION TAG SEQADV 3SA1 HIS A 0 UNP Q81R22 EXPRESSION TAG SEQADV 3SA1 ARG A 2 UNP Q81R22 ILE 2 ENGINEERED MUTATION SEQADV 3SA1 HIS B -2 UNP Q81R22 EXPRESSION TAG SEQADV 3SA1 HIS B -1 UNP Q81R22 EXPRESSION TAG SEQADV 3SA1 HIS B 0 UNP Q81R22 EXPRESSION TAG SEQADV 3SA1 ARG B 2 UNP Q81R22 ILE 2 ENGINEERED MUTATION SEQRES 1 A 165 HIS HIS HIS MET ARG VAL SER PHE MET VAL ALA MET ASP SEQRES 2 A 165 GLU ASN ARG VAL ILE GLY LYS ASP ASN ASN LEU PRO TRP SEQRES 3 A 165 ARG LEU PRO SER GLU LEU GLN TYR VAL LYS LYS THR THR SEQRES 4 A 165 MET GLY HIS PRO LEU ILE MET GLY ARG LYS ASN TYR GLU SEQRES 5 A 165 ALA ILE GLY ARG PRO LEU PRO GLY ARG ARG ASN ILE ILE SEQRES 6 A 165 VAL THR ARG ASN GLU GLY TYR HIS VAL GLU GLY CYS GLU SEQRES 7 A 165 VAL ALA HIS SER VAL GLU GLU VAL PHE GLU LEU CYS LYS SEQRES 8 A 165 ASN GLU GLU GLU ILE PHE ILE PHE GLY GLY ALA GLN ILE SEQRES 9 A 165 TYR ASP LEU PHE LEU PRO TYR VAL ASP LYS LEU TYR ILE SEQRES 10 A 165 THR LYS ILE HIS HIS ALA PHE GLU GLY ASP THR PHE PHE SEQRES 11 A 165 PRO GLU MET ASP MET THR ASN TRP LYS GLU VAL PHE VAL SEQRES 12 A 165 GLU LYS GLY LEU THR ASP GLU LYS ASN PRO TYR THR TYR SEQRES 13 A 165 TYR TYR HIS VAL TYR GLU LYS GLN GLN SEQRES 1 B 165 HIS HIS HIS MET ARG VAL SER PHE MET VAL ALA MET ASP SEQRES 2 B 165 GLU ASN ARG VAL ILE GLY LYS ASP ASN ASN LEU PRO TRP SEQRES 3 B 165 ARG LEU PRO SER GLU LEU GLN TYR VAL LYS LYS THR THR SEQRES 4 B 165 MET GLY HIS PRO LEU ILE MET GLY ARG LYS ASN TYR GLU SEQRES 5 B 165 ALA ILE GLY ARG PRO LEU PRO GLY ARG ARG ASN ILE ILE SEQRES 6 B 165 VAL THR ARG ASN GLU GLY TYR HIS VAL GLU GLY CYS GLU SEQRES 7 B 165 VAL ALA HIS SER VAL GLU GLU VAL PHE GLU LEU CYS LYS SEQRES 8 B 165 ASN GLU GLU GLU ILE PHE ILE PHE GLY GLY ALA GLN ILE SEQRES 9 B 165 TYR ASP LEU PHE LEU PRO TYR VAL ASP LYS LEU TYR ILE SEQRES 10 B 165 THR LYS ILE HIS HIS ALA PHE GLU GLY ASP THR PHE PHE SEQRES 11 B 165 PRO GLU MET ASP MET THR ASN TRP LYS GLU VAL PHE VAL SEQRES 12 B 165 GLU LYS GLY LEU THR ASP GLU LYS ASN PRO TYR THR TYR SEQRES 13 B 165 TYR TYR HIS VAL TYR GLU LYS GLN GLN HET NAP A 207 48 HET 6DR A 163 27 HET NAP B 207 48 HET 6DR B 163 27 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM 6DR 6-ETHYL-5-{3-[2-METHOXY-5-(PYRIDIN-4-YL)PHENYL]PROP-1- HETNAM 2 6DR YN-1-YL}PYRIMIDINE-2,4-DIAMINE HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 3 NAP 2(C21 H28 N7 O17 P3) FORMUL 4 6DR 2(C21 H21 N5 O) FORMUL 7 HOH *35(H2 O) HELIX 1 1 LEU A 25 MET A 37 1 13 HELIX 2 2 ARG A 45 GLY A 52 1 8 HELIX 3 3 SER A 79 CYS A 87 1 9 HELIX 4 4 GLY A 98 LEU A 106 1 9 HELIX 5 5 PRO A 107 VAL A 109 5 3 HELIX 6 6 LEU B 25 MET B 37 1 13 HELIX 7 7 ARG B 45 GLY B 52 1 8 HELIX 8 8 SER B 79 CYS B 87 1 9 HELIX 9 9 GLY B 98 LEU B 106 1 9 HELIX 10 10 PRO B 107 VAL B 109 5 3 SHEET 1 A16 GLU A 75 ALA A 77 0 SHEET 2 A16 ASN A 60 VAL A 63 1 N ASN A 60 O GLU A 75 SHEET 3 A16 LEU A 41 GLY A 44 1 N MET A 43 O ILE A 61 SHEET 4 A16 GLU A 92 ILE A 95 1 O PHE A 94 N ILE A 42 SHEET 5 A16 ARG A 2 ASP A 10 1 N SER A 4 O ILE A 95 SHEET 6 A16 LYS A 111 ILE A 117 1 O ILE A 117 N MET A 9 SHEET 7 A16 TYR A 153 LYS A 160 -1 O TYR A 158 N LEU A 112 SHEET 8 A16 TRP A 135 LYS A 142 -1 N GLU A 141 O TYR A 155 SHEET 9 A16 TRP B 135 LYS B 142 1 O VAL B 140 N GLU A 137 SHEET 10 A16 TYR B 153 LYS B 160 -1 O TYR B 155 N GLU B 141 SHEET 11 A16 LYS B 111 ILE B 117 -1 N LEU B 112 O TYR B 158 SHEET 12 A16 ARG B 2 ASP B 10 1 N PHE B 5 O TYR B 113 SHEET 13 A16 GLU B 92 ILE B 95 1 O ILE B 95 N SER B 4 SHEET 14 A16 LEU B 41 GLY B 44 1 N ILE B 42 O PHE B 94 SHEET 15 A16 ASN B 60 VAL B 63 1 O ILE B 61 N MET B 43 SHEET 16 A16 GLU B 75 ALA B 77 1 O GLU B 75 N ASN B 60 SHEET 1 B 2 VAL A 14 GLY A 16 0 SHEET 2 B 2 THR A 125 PHE A 126 -1 O THR A 125 N ILE A 15 SHEET 1 C 2 VAL B 14 GLY B 16 0 SHEET 2 C 2 THR B 125 PHE B 126 -1 O THR B 125 N ILE B 15 CISPEP 1 GLY A 97 GLY A 98 0 2.26 CISPEP 2 GLY B 97 GLY B 98 0 4.17 SITE 1 AC1 25 VAL A 7 ALA A 8 ILE A 15 ASN A 19 SITE 2 AC1 25 ASN A 20 LEU A 21 GLY A 44 ARG A 45 SITE 3 AC1 25 LYS A 46 ASN A 47 VAL A 63 THR A 64 SITE 4 AC1 25 ARG A 65 HIS A 78 PHE A 96 GLY A 97 SITE 5 AC1 25 GLY A 98 ALA A 99 GLN A 100 ILE A 101 SITE 6 AC1 25 TYR A 102 LEU A 104 6DR A 163 HOH A 164 SITE 7 AC1 25 HOH A 169 SITE 1 AC2 15 MET A 6 VAL A 7 ALA A 8 ASN A 20 SITE 2 AC2 15 LEU A 21 GLU A 28 VAL A 32 LYS A 33 SITE 3 AC2 15 ASN A 47 ALA A 50 ARG A 53 LEU A 55 SITE 4 AC2 15 PHE A 96 HOH A 169 NAP A 207 SITE 1 AC3 27 VAL B 7 ALA B 8 ILE B 15 GLY B 16 SITE 2 AC3 27 ASN B 19 ASN B 20 LEU B 21 TRP B 23 SITE 3 AC3 27 GLY B 44 ARG B 45 LYS B 46 ASN B 47 SITE 4 AC3 27 VAL B 63 THR B 64 ARG B 65 HIS B 78 SITE 5 AC3 27 PHE B 96 GLY B 97 GLY B 98 ALA B 99 SITE 6 AC3 27 GLN B 100 ILE B 101 TYR B 102 LEU B 104 SITE 7 AC3 27 6DR B 163 HOH B 171 HOH B 172 SITE 1 AC4 12 MET B 6 VAL B 7 ALA B 8 LEU B 21 SITE 2 AC4 12 TRP B 23 GLU B 28 VAL B 32 ASN B 47 SITE 3 AC4 12 ALA B 50 ILE B 51 PHE B 96 NAP B 207 CRYST1 78.094 78.094 67.070 90.00 90.00 90.00 P 42 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012805 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012805 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014910 0.00000